Genzyme Molecular
Oncology (GMO) provided research support to KWK and has licensed
the SAGE technology1 from The Johns Hopkins University
for commercial purposes; the technology is freely available
to academia for research purposes. The University and researchers
(KWK and BV) have a financial interest in GMO, the arrangements
for which are managed by the University in accordance with
its conflict of interest policies.